Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosisEmiliano Trías, Luis Barbeito|Journal of Neuroinflammation|2016Cited by 148